CJSC SKY LTD

DEVELOPMENT OF MEDICATIONS
ON THE BASIS OF ACHIEVEMENTS IN
MOLECULAR BIOLOGY

 ABOUT COMPANY 
CJSC SKY LTD – is a biotechnological company that focuses on the development of innovative medicaments and its further application to pharmaceutical market.
The company realizes a full cycle of medicament development from preclinical studies, development of a pharmaceutical dosage form, clinical studies and medicaments registration for its clinical use.

Our approach to the development of new medicaments is based on the achievements of Russian scientists in the field of molecular biology.

Our goal is to create a portfolio of medicaments that have competitive advantages in the field of significant medical challenges and that are able to demonstrate commercial success.

 HISTORY 
  • SKY LTD Closed Joint-Stock Company was founded in 1997 as an investment company.

  • A Research Laboratory was created in Moscow in 1998 and the necessary staff of qualified specialists was recruited.

  • Since 2001, the Company begins to invest in promising projects in the field of medicine. The hardware — medical complex SAI-01-B, made by the method of Professor A. Stupko, became the first project in medicine in the treatment of chronic inflammatory diseases of the genitourinary system.

  • In 2002, several Biologically Active Food Additives based on plant materials were developed and registered.

  • In 2003, SKY LTD CJSC focused on investment in scientific developments in the field of molecular biology. Toward this end, the Company works in close cooperation with leading institutes, laboratories, and clinical institutions of Russia, focusing its efforts on creation of new medicaments in the field of immunology, oncology and gynecology.

  • In 2008, the company registered in Russia an original medicament of its own development — the immunostimulating agent Stimforte — for herpes virus infections and furunculosis treatment.

  • In 2010, the Company’s portfolio was replenished with a medicament for hepatitis B treatment.

  • In 2014, the Company registered in Belarus its own development, which has no analogues in the world, — the medicament «Endoferin». A year later, «Belmedpreparaty» coped with edition «Endoferin» in its production areas.

  • At the end of 2017, CJSC SKY LTD starts actions aimed at Endoferin registration in Russia.

  • The Company’s portfolio is constantly updated with new scientific developments based on research in the field of immunology, gynecology, oncology, infectology.